These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 16530532
1. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. Gastroenterology; 2006 Mar; 130(3):940-87. PubMed ID: 16530532 [No Abstract] [Full Text] [Related]
2. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. Gastroenterology; 2006 Mar; 130(3):935-9. PubMed ID: 16530531 [No Abstract] [Full Text] [Related]
3. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease]. Lichtenstein GR, Sbreu MT, Cohen R, Tremaine W. Rev Gastroenterol Mex; 2006 Mar; 71(3):351-401. PubMed ID: 17140062 [No Abstract] [Full Text] [Related]
8. Efficacy of conventional immunosuppressive drugs in IBD. Caprilli R, Angelucci E, Cocco A, Viscido A, Zippi M. Dig Liver Dis; 2004 Nov 12; 36(11):766-80. PubMed ID: 15571009 [Abstract] [Full Text] [Related]
9. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ. Am J Gastroenterol; 1996 Mar 12; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
11. Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease. Ben-Horin S, Waterman M, Kopylov U, Yavzori M, Picard O, Fudim E, Awadie H, Weiss B, Chowers Y. Clin Gastroenterol Hepatol; 2013 Apr 12; 11(4):444-7. PubMed ID: 23103905 [Abstract] [Full Text] [Related]
12. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. Nutan F, Ortega-Loayza AG. J Investig Dermatol Symp Proc; 2017 Oct 12; 18(2):S64-S68. PubMed ID: 28941497 [Abstract] [Full Text] [Related]
15. General principles of medical therapy of inflammatory bowel disease. Friedman S. Gastroenterol Clin North Am; 2004 Jun 12; 33(2):191-208, viii. PubMed ID: 15177534 [Abstract] [Full Text] [Related]
17. Balancing efficacy and toxicity in kidney-transplant immunosuppression. Leichtman AB. N Engl J Med; 2007 Dec 20; 357(25):2625-7. PubMed ID: 18094383 [No Abstract] [Full Text] [Related]
18. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Bousvaros A. Expert Rev Clin Immunol; 2010 Jul 20; 6(4):659-66. PubMed ID: 20594138 [Abstract] [Full Text] [Related]